Spire Healthcare Group PLC (SPI) Given Average Rating of “Hold” by Brokerages
Shares of Spire Healthcare Group PLC (LON:SPI) have earned an average recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is GBX 304.29 ($4.20).
A number of brokerages recently issued reports on SPI. Barclays began coverage on Spire Healthcare Group in a research report on Friday, February 2nd. They set an “equal weight” rating and a GBX 270 ($3.73) price objective for the company. Liberum Capital raised their price objective on Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the stock a “hold” rating in a research report on Friday, January 26th. Numis Securities reissued an “add” rating and set a GBX 296 ($4.09) price objective on shares of Spire Healthcare Group in a research report on Tuesday, January 16th. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 339 ($4.68) price objective on shares of Spire Healthcare Group in a research report on Thursday, January 4th. Finally, Jefferies Group raised Spire Healthcare Group to a “buy” rating and raised their price objective for the stock from GBX 259 ($3.58) to GBX 290 ($4.01) in a research report on Wednesday, January 17th.
In other news, insider Peter R. Bamford bought 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was bought at an average cost of GBX 240 ($3.32) per share, with a total value of £12,000 ($16,579.17). Also, insider Justin Ash bought 84,500 shares of the company’s stock in a transaction on Thursday, November 23rd. The stock was purchased at an average cost of GBX 237 ($3.27) per share, with a total value of £200,265 ($276,685.55).
About Spire Healthcare Group
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.